Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
Na Zhang, Jianjun Jiang, Sihui Tang, Gengyun Sun
Topics & Concepts
MedicineInternal medicineNivolumabAtezolizumabHazard ratioSubgroup analysisLung cancerPembrolizumabMeta-analysisOncologyNeutrophil to lymphocyte ratioLymphocyteConfidence intervalGastroenterologyCancerImmunotherapyInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersImmune cells in cancer